DyDo Group Holdings, Inc. (TYO:2590)

Revance Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Jan 20, 2025	Jan 20, 2024	Jan 20, 2023	Jan 20, 2022	Jan 20, 2021
Market Capitalization	85,167	106,173	91,700	73,420	71,951	80,878
Market Cap Growth	13.15%	15.78%	24.90%	2.04%	-11.04%	11.97%
Enterprise Value	79,483	91,759	75,723	59,928	55,065	63,539
Last Close Price	2694.00	3346.36	2862.47	2263.42	2203.97	2422.59
PE Ratio	-	27.91	20.73	-	18.11	25.24
Forward PE	43.66	27.70	52.16	141.77	23.76	26.03
PS Ratio	0.36	0.45	0.43	0.46	0.44	0.51
PB Ratio	0.96	1.14	1.00	0.87	0.86	0.98
P/TBV Ratio	1.11	1.33	1.13	0.97	0.97	1.11
P/FCF Ratio	-	4246.94	-	-	-	18.34
P/OCF Ratio	-	9.81	9.96	14.33	8.93	6.45
EV/Sales Ratio	0.34	0.39	0.36	0.37	0.34	0.40
EV/EBITDA Ratio	5.09	5.75	5.85	6.85	4.64	5.14
EV/EBIT Ratio	20.10	19.16	20.29	84.64	12.02	11.34
EV/FCF Ratio	-	3670.38	-	-	-	14.41
Debt / Equity Ratio	0.38	0.38	0.37	0.41	0.41	0.42
Debt / EBITDA Ratio	2.18	2.20	2.59	3.95	2.84	2.82
Debt / FCF Ratio	-	1402.72	-	-	-	7.91
Asset Turnover	1.25	1.31	1.25	0.99	1.03	0.99
Inventory Turnover	7.51	8.49	8.88	8.57	9.24	9.03
Quick Ratio	1.01	1.18	1.50	1.58	1.76	1.86
Current Ratio	1.39	1.45	1.83	1.87	2.03	2.11
Return on Equity (ROE)	-3.28%	3.71%	5.27%	-0.59%	4.75%	3.67%
Return on Assets (ROA)	1.31%	1.65%	1.36%	0.27%	1.81%	2.18%
Return on Capital (ROIC)	1.99%	2.36%	1.92%	0.38%	2.44%	2.94%
Return on Capital Employed (ROCE)	3.30%	3.90%	2.90%	0.60%	3.80%	4.70%
Earnings Yield	-2.57%	3.58%	4.82%	-0.69%	5.52%	3.96%
FCF Yield	-	0.02%	-1.85%	-4.59%	-1.86%	5.45%
Dividend Yield	1.12%	0.90%	1.05%	1.32%	1.36%	1.24%
Payout Ratio	-	25.08%	21.55%	-	23.98%	30.37%
Buyback Yield / Dilution	-0.36%	-0.35%	-0.27%	-0.23%	1.79%	3.36%
Total Shareholder Return	0.76%	0.54%	0.78%	1.10%	3.15%	4.60%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.